Physician Recognition of Bioterrorism-Related Diseases

  • Kevin Yeskey
  • Stephen A. Morse


In October 2001, the United States experienced an unprecedented bioterrorist attack associated with the intentional release of Bacillus anthracis through mailed letters and packages (1) . Five deaths and 17 other cases of anthrax were confirmed. Clinicians and clinical laboratories had a primary role in the response to this attack. One of the most important lessons has been the recognition that the capacity to respond effectively depends largely on the local efforts, particularly among clinicians, hospitals, and the public health departments. The Centers for Disease Control and Prevention (CDC) is working to strengthen the local response by helping to ensure that all frontline clinicians have a baseline set of information to recognize and treat bioterrorism-related diseases and to exclude these diseases as part of the differential diagnosis. Furthermore, it is important that physicians recognize their role as first responders in a covert bioterrorism attack.


Bacillus Anthracis Yersinia Pestis Biological Weapon Francisella Tularensis Lassa Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933–944.PubMedCrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. Notice to readers: ongoing investigation of anthrax— Florida, October 2001. MMWR 2001;50:877.Google Scholar
  3. 3.
    Mims C, Plavfair J, Roitt I, et al. Medical Microbiology, 2nd ed. Mosby, London, 1998.Google Scholar
  4. 4.
    Eitzen EM. Use of biological weapons. In: Sidell FR, Takafuji ET, Franz DR, eds. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Borden Institute, Washington, DC, 1997, pp. 437–450.Google Scholar
  5. 5.
    Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon. Medical and public health management. JAMA 2000;283:2281–2290.PubMedCrossRefGoogle Scholar
  6. 6.
    Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon. Medical and public health management. JAMA 2001;285:2763–2773.PubMedCrossRefGoogle Scholar
  7. 7.
    Inglesby TV, O’Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002. Updated recommendations for management. JAMA 2002;287:2236–2252.PubMedCrossRefGoogle Scholar
  8. 8.
    Khan AS, Morse S, Lillibridge S. Public-health preparedness for biological terrorism in the USA. Lancet 2000;356:1179–1182.PubMedCrossRefGoogle Scholar
  9. 9.
    Noah D, Sobel A, Ostroff S, Kildew J. Biological warfare training: infectious disease outbreak differentiation criteria. Mil Med 1998;163:198–201.PubMedGoogle Scholar
  10. 10.
    Shooter RA. Report of the investigation into the cause of the 1978 Birmingham smallpox occurrence. London: Her Majesty’s Stationery Office, 1980.Google Scholar
  11. 11.
    Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002;346: 1300–1308.PubMedCrossRefGoogle Scholar
  12. 12.
    Centers for Disease Control and Prevention. Outbreak of West Nile-like viral encephalitis—New York, 1999. MMWR 1999;48:845–849.Google Scholar
  13. 13.
    Johns Hopkins Center for Civilian Biodefense Strategies:
  14. 14.
    Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon. Medical and public health management. J.A.M.A. 1999:281:2127–2137.PubMedCrossRefGoogle Scholar
  15. 15.
    Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon. Medical and public health management. JAMA 2001:285:1059–1070.PubMedCrossRefGoogle Scholar
  16. 16.
    Borio L, Inglesby TV, Peters CJ, et al. Hemorrhagic fever viruses as biological weapons. Medical and public health management. JAMA 2002;287:2391–2405.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2004

Authors and Affiliations

  • Kevin Yeskey
  • Stephen A. Morse

There are no affiliations available

Personalised recommendations